Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis | Zendy

Amyn A. Malik | Zendy; Meredith B. Brooks | Zendy; Sara Siddiqui | Zendy; Junaid Fuad | Zendy; Charles A. Peloquin | Zendy; Farhana Amanullah | Zendy; Maria Jaswal | Zendy; Mercedes C. Becerra | Zendy; Hamidah Hussain | Zendy; Courtney M. Yuen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis

Author(s) -

Amyn A. Malik,

Meredith B. Brooks,

Sara Siddiqui,

Junaid Fuad,

Charles A. Peloquin,

Farhana Amanullah,

Maria Jaswal,

Mercedes C. Becerra,

Hamidah Hussain,

Courtney M. Yuen

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02569-18

Subject(s) - levofloxacin , medicine , pharmacokinetics , tuberculosis , drug , ofloxacin , pharmacology , drug resistant tuberculosis , drug resistance , antibacterial agent , mycobacterium tuberculosis , antibiotics , ciprofloxacin , microbiology and biotechnology , pathology , biology

Levofloxacin is used to treat and prevent drug-resistant tuberculosis in children. We assessed levofloxacin serum drug concentrations in 24 children aged 2 to 10 years who received levofloxacin-based tuberculosis preventive therapy in Karachi, Pakistan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research